Horizon Therapeutics, LLC   Report issue

Founded: Brisbane CA United States (2006)

Organization Overview

First Clinical Trial
2010
NCT01257737
First Marketed Drug
2006
sodium phenylbutyrate (buphenyl)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

HORIZON THERAP | Horizon Therapeutics | HORIZON THERAPEUTICS IRELAND | Horizon Therapeutics Ireland DAC | Horizon Therapeutics, LLC | Horizon Therapeutics USA, Inc.